Cyfuse Biomedical K.K.'s total assets for Q4 2024 were ¥3.52B, a decrease of -3.77% from the previous quarter. JP:4892 total liabilities were ¥976.00M for the fiscal quarter, a 4.83% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.